HIGHLIGHTS
- who: Min Kyu Yang and collaborators from the Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, Department of Ophthalmology, Myongji Hospital, Gyeonggi-do, Republic of Korea have published the Article: Efficacy and safety of intravenous glucocorticoid therapy for IgG4-related ophthalmic disease, in the Journal: PLOS ONE of January/12,/2023
- what: This study aimed to evaluate and compare the efficacy and safety of IV glucocorticoid therapy with those of oral glucocorticoids as a first-line treatment for IgG4-ROD.
- how: Regarding the dose and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.